Molecular Partners Ag ADR (MOLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 5,645 | 7,840 | 198,682 | 10,672 | 9,966 |
| Cost of Goods | 55,209 | 54,341 | 53,180 | 60,961 | 59,810 |
| Gross Profit | -49,564 | -46,501 | 145,502 | -50,289 | -49,843 |
| Operating Expenses | 20,182 | 21,908 | 23,483 | 20,058 | 13,177 |
| Operating Income | -69,536 | -68,068 | 122,199 | -69,386 | -62,211 |
| Interest Expense | 43 | 5,742 | 649 | 608 | 5,137 |
| Other Income | 8,194 | 4,766 | 1,948 | 209 | 391 |
| Pre-tax Income | -61,385 | -69,044 | 123,498 | -69,785 | -66,956 |
| Income Tax | 2 | N/A | N/A | 2 | -12 |
| Net Income Continuous | -61,388 | -69,044 | 123,498 | -69,787 | -66,944 |
| Net Income | $-61,387 | $-69,044 | $123,498 | $-69,787 | $-66,944 |
| EPS Basic Total Ops | -1.81 | -2.11 | 3.80 | -2.25 | -2.68 |
| EPS Basic Continuous Ops | -1.80 | -2.11 | 3.80 | -2.25 | -2.68 |
| EPS Diluted Total Ops | -1.81 | -2.11 | 3.71 | -2.25 | -2.68 |
| EPS Diluted Continuous Ops | -1.80 | -2.11 | 3.71 | -2.25 | -2.68 |
| EPS Diluted Before Non-Recurring Items | -1.81 | -2.10 | 3.71 | -2.25 | N/A |
| EBITDA(a) | $-66,845 | $-65,373 | $124,701 | $-66,579 | $-59,131 |